SUMO2 regulates vascular endothelial function and oxidative stress in mice

Area of Science:

• Vascular Biology
• Posttranslational Modifications
• Endocrinology

Background:

• Sumoylation, a posttranslational modification, involves small ubiquitin-like modifiers (SUMO)1, -2, and -3.
• SUMOylation can lead to diverse physiological and pathological outcomes.
• The specific roles of individual SUMO proteins in vascular endothelial function remain unclear.

Purpose of the Study:

• To investigate the specific role of SUMO2 in vascular endothelial function.
• To determine the impact of SUMO2 on endothelium-dependent vasorelaxation and oxidative stress.
• To elucidate the contribution of SUMO2 to hypercholesterolemia-induced endothelial dysfunction.

Main Methods:

• Analysis of SUMO2 expression in aortic endothelium of hypercholesterolemic mice.
• Ex vivo and in vitro studies involving SUMO2 overexpression in aortas and endothelial cells.
• Transgenic mouse models to assess endothelial-specific SUMO2 effects.
• Pharmacological inhibition of SUMO2 in normocholesterolemic mice.

Main Results:

• SUMO2 expression was elevated in the aortic endothelium of hypercholesterolemic mice.
• SUMO2 overexpression increased vascular oxidative stress and impaired vasorelaxation.
• Inhibition of SUMO2 diminished normal endothelium-dependent vasorelaxation.
• Hyper-SUMO2ylation contributes to hypercholesterolemia-induced endothelial dysfunction.

Conclusions:

• While endogenous SUMO2 is vital for normal vascular endothelial function, its upregulation under hypercholesterolemia exacerbates endothelial dysfunction.
• Increased SUMO2 levels promote vascular oxidative stress and impair vasorelaxation.
• Targeting SUMO2 may offer therapeutic potential for hypercholesterolemia-related vascular complications.